Home

NEW YORK (Reuters) - Lynn Redgrave, a leading member of a British acting dynasty who was nominated for Oscars in 1966 for "Georgy Girl" and in 1998 for "Gods and Monsters," has died of breast cancer, her family said on Monday. Redgrave died at the age of 67 on Sunday night at her home in Connecticut, her publicist Rick Miramontez said ...

Lynn Redgrave, an introspective and independent player in her family's acting dynasty who became a 1960s sensation as the unconventional title character of "Georgy Girl" and later dramatized her troubled past in such one-woman stage performances as "Shakespeare for My Father" and "Nightingale," has died. She ...

WASHINGTON (Reuters) - Roche Holding AG, Sanofi-Aventis SA and Adolor Corp made misleading claims about cancer, HIV and bowel drugs, U.S. regulators said in letters released on Friday. The Food and Drug Administration objected to a video for consumers from Roche unit Genentech about cancer drug Herceptin. The video "minimizes the serious risks associated with the use of Herceptin and ...

WASHINGTON (Reuters) - Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co's Evista, but with a greater risk of some other cancers and blood clots. After nearly seven years of follow-up, researchers found that women who took tamoxifen for five years were less likely to ...

Older women at higher risk for breast cancer now have two good drug options for preventing the disease, but they will have to weigh the trade-offs, a major study shows. Tamoxifen, the longtime gold standard, is more effective and longer lasting, the results show. But a newer drug — raloxifene ...